Elisa A Rozeman

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 12

Top Topics

Endoscopic Submucosal Dissection

Basal Cell Carcinoma

Top Venues

Cancer research communications

American journal of clinical dermatology

This page only lists publications with an associated author ORCID identifier.

Publications

Elisa A Rozeman, Jason John Luke
The emergence of neoadjuvant immune-over BRAF therapy in melanoma. Cancer (2024)
Elisa A Rozeman, Jason John Luke
The emergence of neoadjuvant immune-over BRAF therapy in melanoma. Cancer (2024)
Esmée P Hoefsmit, Franziska Völlmy, Elisa A Rozeman, Irene L M Reijers, Judith M Versluis, Liesbeth Hoekman, Alexander C J van Akkooi, Georgina V Long, Dirk Schadendorf, Reinhard Dummer, A F Maarten Altelaar, Christian U Blank
Systemic LRG1 Expression in Melanoma is Associated with Disease Progression and Recurrence. Cancer research communications 3 (4) (2023)
Esmée P Hoefsmit, Franziska Völlmy, Elisa A Rozeman, Irene L M Reijers, Judith M Versluis, Liesbeth Hoekman, Alexander C J van Akkooi, Georgina V Long, Dirk Schadendorf, Reinhard Dummer, A F Maarten Altelaar, Christian U Blank
Systemic LRG1 Expression in Melanoma is Associated with Disease Progression and Recurrence. Cancer research communications 3 (4) (2023)
Esmée P Hoefsmit, Paula T van Royen, Disha Rao, Johanna A Stunnenberg, Petros Dimitriadis, Cor Lieftink, Ben Morris, Elisa A Rozeman, Irene L M Reijers, Ruben Lacroix, Huma Shehwana, Maarten A Ligtenberg, Roderick L Beijersbergen, Daniel S Peeper, Christian U Blank
Inhibitor of apoptosis proteins (IAP) antagonist induces T-cell proliferation after cross-presentation by dendritic cells. Cancer immunology research (2023)
Esmée P Hoefsmit, Franziska Völlmy, Elisa A Rozeman, Irene L M Reijers, Judith M Versluis, Liesbeth Hoekman, Alexander C J van Akkooi, Georgina V Long, Dirk Schadendorf, Reinhard Dummer, A F Maarten Altelaar, Christian U Blank
Systemic LRG1 Expression in Melanoma is Associated with Disease Progression and Recurrence. Cancer research communications 3 (4) (2023)
Elisa A Rozeman, Judith M Versluis, Karolina Sikorska, Esmée P Hoefsmit, Petros Dimitriadis, Disha Rao, Ruben Lacroix, Lindsay G Grijpink-Ongering, Marta Lopez-Yurda, Birthe C Heeres, Bart A van de Wiel, Claudie Flohil, Aysegul Sari, Stijn W T P J Heijmink, Daan van den Broek, Annegien Broeks, Jan Willem B de Groot, Marieke A Vollebergh, Sofie Wilgenhof, Johannes V van Thienen, John B A G Haanen, Christian U Blank
IMPemBra: a phase 2 study comparing pembrolizumab with intermittent/short-term dual MAPK pathway inhibition plus pembrolizumab in patients with melanoma harboring the BRAFV600 mutation. Journal for immunotherapy of cancer 11 (7) (2023)
Esmée P Hoefsmit, Franziska Völlmy, Elisa A Rozeman, Irene L M Reijers, Judith M Versluis, Liesbeth Hoekman, Alexander C J van Akkooi, Georgina V Long, Dirk Schadendorf, Reinhard Dummer, A F Maarten Altelaar, Christian U Blank
Systemic LRG1 Expression in Melanoma is Associated with Disease Progression and Recurrence. Cancer research communications 3 (4) (2023)
Irene L M Reijers, Elisa A Rozeman, Sofie Wilgenhof, Johannes V van Thienen, John B A G Haanen, Christian U Blank
Switch to checkpoint inhibition after targeted therapy at time of progression or during ongoing response: A retrospective single-centre experience in patients with BRAF-mutated melanoma. Pigment cell & melanoma research 33 (3) (2019)
Esmée P Hoefsmit, Elisa A Rozeman, John B A G Haanen, Christian U Blank
Susceptible loci associated with autoimmune disease as potential biomarkers for checkpoint inhibitor-induced immune-related adverse events. ESMO open 4 (4) (2019)
Marnix H Geukes Foppen, Elisa A Rozeman, Sandra van Wilpe, Cindy Postma, Petur Snaebjornsson, Johannes V van Thienen, Monique E van Leerdam, Michel van den Heuvel, Christian U Blank, Jolanda van Dieren, John B A G Haanen
Immune checkpoint inhibition-related colitis: symptoms, endoscopic features, histology and response to management. ESMO open 3 (1) (2018)
Elisa A Rozeman, Tim J A Dekker, John B A G Haanen, Christian U Blank
Advanced Melanoma: Current Treatment Options, Biomarkers, and Future Perspectives. American journal of clinical dermatology 19 (3) (2018)